{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:29:04Z","timestamp":1793730544693,"version":"4.6.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40120-020-00206-3","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T19:03:51Z","timestamp":1598555031000},"page":"575-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3542-8181","authenticated-orcid":false,"given":"Dylan","family":"Trundell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Le Scouiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenija","family":"Gorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Seabrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Vuillerot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the SMA MFM Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"issue":"5","key":"206_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","volume":"11","author":"E Mercuri","year":"2012","unstructured":"Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012;11(5):443\u201352.","journal-title":"Lancet Neurol"},{"key":"206_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-6-71","volume":"6","author":"A D'Amico","year":"2011","unstructured":"D'Amico A, Mercuri E, Tiziano FD, Bertini E. Spinal muscular atrophy. Orphanet J Rare Dis. 2011;6:71.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"206_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","volume":"51","author":"WD Arnold","year":"2015","unstructured":"Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015;51(2):157\u201367.","journal-title":"Muscle Nerve"},{"issue":"7","key":"206_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","volume":"15","author":"C Berard","year":"2005","unstructured":"Berard C, Payan C, Hodgkinson I, Fermanian J, Group MFMCS. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15(7):463\u201370.","journal-title":"Neuromuscul Disord."},{"issue":"8","key":"206_CR5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.apmr.2013.01.014","volume":"94","author":"C Vuillerot","year":"2013","unstructured":"Vuillerot C, Payan C, Iwaz J, Ecochard R, Berard C, MFM Spinal Muscular Atrophy Study Group. Responsiveness of the motor function measure in patients with spinal muscular atrophy. Arch Phys Med Rehabil. 2013;94(8):1555\u2013611.","journal-title":"Arch Phys Med Rehabil."},{"issue":"7","key":"206_CR6","doi-asserted-by":"publisher","first-page":"e0201004","DOI":"10.1371\/journal.pone.0201004","volume":"13","author":"A Chabanon","year":"2018","unstructured":"Chabanon A, Seferian AM, Daron A, et al. Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: baseline data NatHis-SMA study. PLoS ONE. 2018;13(7):e0201004.","journal-title":"PLoS ONE"},{"issue":"11","key":"206_CR7","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.apmr.2013.04.001","volume":"94","author":"C de Lattre","year":"2013","unstructured":"de Lattre C, Payan C, Vuillerot C, et al. Motor function measure: validation of a short form for young children with neuromuscular diseases. Arch Phys Med Rehabil. 2013;94(11):2218\u201326.","journal-title":"Arch Phys Med Rehabil"},{"key":"206_CR8","unstructured":"ClinicalTrials.gov. A study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RO7034067 in Type 2 and 3 spinal muscular atrophy (SMA) participants (SUNFISH). 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02908685?term=SUNFISH&rank=1. Accessed July 2020."},{"key":"206_CR9","unstructured":"[No authors listed]. ICH Harmonized Tripartite Guideline. Guideline for good clinical practice. J Postgrad Med. 2001;47(3):199\u2013203."},{"key":"206_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S1607-551X(09)70523-6","volume":"25","author":"L Yi-Jing","year":"2009","unstructured":"Yi-Jing L, Rong-Fong L, Shun-Sheng C, Yen-Mou L. Measurement of the function status of patients with different types of muscular dystrophy. Kaohsiung J Med Sci. 2009;25:325\u201333.","journal-title":"Kaohsiung J Med Sci"},{"issue":"3","key":"206_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/nau.20110","volume":"24","author":"LS Matza","year":"2005","unstructured":"Matza LS, Thompson CL, Krasnow J, Brewster-Jordan J, Zyczynski T, Coyne KS. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn. 2005;24(3):215\u201325.","journal-title":"Neurourol Urodyn"},{"key":"206_CR12","doi-asserted-by":"crossref","unstructured":"Mokkink LB, Prinsen CA, Patrick DL, et al. COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs); user manual. 2018. https:\/\/www.cosmin.nl. Accessed July 2020.","DOI":"10.1007\/s11136-018-1798-3"},{"key":"206_CR13","first-page":"248","volume-title":"The assessment of reliability. Psychometric Theory","author":"JC Nunally","year":"1994","unstructured":"Nunally JC, Bernstein IH. The assessment of reliability. Psychometric Theory. New York: McGraw-Hill; 1994. p. 248\u201392."},{"key":"206_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF02310555","volume":"16","author":"LJ Cronbach","year":"1951","unstructured":"Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297\u2013334.","journal-title":"Psychometrika"},{"key":"206_CR15","unstructured":"Bartz, AE. Basic statistical concepts (4th ed.). 1999. Upper Saddle River, NJ: Prentice Hall, Inc."},{"key":"206_CR16","first-page":"75","volume-title":"Correlation and regression. Statistics at square one","author":"DTV Swinscow","year":"1997","unstructured":"Swinscow DTV. Correlation and regression. Statistics at square one. 9th ed. London: BMJ Publishing; 1997. p. 75\u201384.","edition":"9"},{"issue":"12","key":"206_CR17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1177\/0883073811420294","volume":"26","author":"AM Glanzman","year":"2011","unstructured":"Glanzman AM, O\u2019Hagen JM, McDermott MP, et al. Validation of the expanded hammersmith functional motor scale in spinal muscular atrophy type II and III. J Child Neurol. 2011;26(12):1499\u2013507.","journal-title":"J Child Neurol."}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-020-00206-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T15:23:39Z","timestamp":1712762619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-020-00206-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1007\/s40120-020-00206-3","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"30 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}